Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-007-9737-y.

Title:
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome | Breast Cancer Research and Treatment
Description:
Background Advances in understanding the molecular basis of breast cancer has necessitated a definition of improved indicators of prognosis that are central to the underlying cancer biology and that reflect the heterogeneous nature of the disease. This study investigates the pattern of expression of the steroid receptor co-regulators NCOA1/SRC1, NCOA3/RAC3, NCOR2/SMRT, and CBP/p300 in breast cancer. The aims were to identify whether their expression was related to patient outcome, their relationships to known prognostic factors and to provide a basis for further research into the mechanistic significance of such associations. Methods The protein levels of steroid receptor co-regulators were assessed by immunohistochemistry in a large well-characterised series of breast carcinomas prepared as tissue microarrays. Relationships between these targets, other clinicopathological variables and patients’ outcome were examined. Results NCOR2/SMRT was an independent prognostic indicator of overall patient survival (OS) and disease free interval (DFI) and was significantly correlated with distant metastases and local recurrence whereas tumours expressing NCOA1/SRC1 had a significantly longer OS and DFI. There were also significant correlations between co-regulator expression of NCOA1/SRC1, CBP/p300 and NCOA3/RAC3, which were associated with lower tumour grade. NCOA1/SRC1 was also correlated with smaller tumour size. Furthermore, the co-activators had a significant association with steroid receptors, particularly ERα. Conclusions NCOR2/SMRT is associated with poor patient outcome, independent of other prognostic factors. In contrast, steroid receptor co-activator expression is generally associated with a good prognosis. Further investigations are needed to establish the mechanisms of these links between the steroid receptor co-regulator system and patient outcome.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, breast, article, google, scholar, pubmed, cas, receptor, expression, steroid, prognostic, receptors, estrogen, res, ellis, coactivator, nottingham, outcome, tissue, access, research, coregulators, ncorsmrt, green, paish, aib, clin, privacy, cookies, content, significance, poor, rakha, macmillan, molecular, nature, ncoasrc, tumours, tumour, human, blamey, publish, search, independent, study, claire, cbpp, patient, factors, protein,

Topics {✒️}

month download article/chapter repressor ncor2/smrt endocrine-resistant breast cancer tumours expressing ncoa1/src1 mediates nuclear-receptor function high-throughput molecular profiling el-rehim da mccarty ks sr triple-negative breast cancer ncoa3/rac3 cbp/p300 interact results ncor2/smrt conclusions ncor2/smrt full article pdf nuclear coactivator aib1 van de rijn estrogen receptors alpha sex steroid receptors estrogen receptor analyses privacy choices/manage cookies /cip binds cbp improved indicators prognostic markers somaia el-sheikh malignant breast tissue basal phenotype identifies breast cancer growth tissue microarray technology related subjects cbp/p300 poor prognostic subgroup src-1 predicts outcome ncor2/smrt steroid receptor coactivator-1 estrogen receptor-alpha regulators ncoa1/src1 human breast tumours breast tumours correlates nottingham prognostic index metastatic breast cancer breast cancer correlates human breast cancer primary breast cancer breast cancer campaign pathological prognostic factors breast carcinomas prepared estrogen receptor activity estrogen-positive tumours uk andrew fleming fj

Questions {❓}

  • Dobrzycka KM, Townson SM, Jiang S, Oesterreich S (2003) Estrogen receptor corepressors–a role in human breast cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
         description:Advances in understanding the molecular basis of breast cancer has necessitated a definition of improved indicators of prognosis that are central to the underlying cancer biology and that reflect the heterogeneous nature of the disease. This study investigates the pattern of expression of the steroid receptor co-regulators NCOA1/SRC1, NCOA3/RAC3, NCOR2/SMRT, and CBP/p300 in breast cancer. The aims were to identify whether their expression was related to patient outcome, their relationships to known prognostic factors and to provide a basis for further research into the mechanistic significance of such associations. The protein levels of steroid receptor co-regulators were assessed by immunohistochemistry in a large well-characterised series of breast carcinomas prepared as tissue microarrays. Relationships between these targets, other clinicopathological variables and patients’ outcome were examined. NCOR2/SMRT was an independent prognostic indicator of overall patient survival (OS) and disease free interval (DFI) and was significantly correlated with distant metastases and local recurrence whereas tumours expressing NCOA1/SRC1 had a significantly longer OS and DFI. There were also significant correlations between co-regulator expression of NCOA1/SRC1, CBP/p300 and NCOA3/RAC3, which were associated with lower tumour grade. NCOA1/SRC1 was also correlated with smaller tumour size. Furthermore, the co-activators had a significant association with steroid receptors, particularly ERα. NCOR2/SMRT is associated with poor patient outcome, independent of other prognostic factors. In contrast, steroid receptor co-activator expression is generally associated with a good prognosis. Further investigations are needed to establish the mechanisms of these links between the steroid receptor co-regulator system and patient outcome.
         datePublished:2007-09-28T00:00:00Z
         dateModified:2007-09-28T00:00:00Z
         pageStart:427
         pageEnd:437
         sameAs:https://doi.org/10.1007/s10549-007-9737-y
         keywords:
            Steroid receptor
            Co-regulator
            Breast cancer
            Co-repressor
            NCOR2/SMRT
            NCOA1/SRC-1
            NCOA3/RAC3
            CBP/p300
            Prognostic indicators
            Tissue micro-arrays
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-007-9737-y/MediaObjects/10549_2007_9737_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-007-9737-y/MediaObjects/10549_2007_9737_Fig2_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:110
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andrew R. Green
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claire Burney
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christopher J. Granger
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Claire Paish
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Somaia El-Sheikh
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emad A. Rakha
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Desmond G. Powe
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Douglas Macmillan
               affiliation:
                     name:Nottingham University Hospitals NHS Trust
                     address:
                        name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ian O. Ellis
               affiliation:
                     name:Nottingham University Hospitals NHS and University of Nottingham
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eleni Stylianou
               affiliation:
                     name:University of Nottingham Medical School, Queen’s Medical Centre
                     address:
                        name:School of Biomedical Sciences and Centre for Biochemistry and Cell Biology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
      description:Advances in understanding the molecular basis of breast cancer has necessitated a definition of improved indicators of prognosis that are central to the underlying cancer biology and that reflect the heterogeneous nature of the disease. This study investigates the pattern of expression of the steroid receptor co-regulators NCOA1/SRC1, NCOA3/RAC3, NCOR2/SMRT, and CBP/p300 in breast cancer. The aims were to identify whether their expression was related to patient outcome, their relationships to known prognostic factors and to provide a basis for further research into the mechanistic significance of such associations. The protein levels of steroid receptor co-regulators were assessed by immunohistochemistry in a large well-characterised series of breast carcinomas prepared as tissue microarrays. Relationships between these targets, other clinicopathological variables and patients’ outcome were examined. NCOR2/SMRT was an independent prognostic indicator of overall patient survival (OS) and disease free interval (DFI) and was significantly correlated with distant metastases and local recurrence whereas tumours expressing NCOA1/SRC1 had a significantly longer OS and DFI. There were also significant correlations between co-regulator expression of NCOA1/SRC1, CBP/p300 and NCOA3/RAC3, which were associated with lower tumour grade. NCOA1/SRC1 was also correlated with smaller tumour size. Furthermore, the co-activators had a significant association with steroid receptors, particularly ERα. NCOR2/SMRT is associated with poor patient outcome, independent of other prognostic factors. In contrast, steroid receptor co-activator expression is generally associated with a good prognosis. Further investigations are needed to establish the mechanisms of these links between the steroid receptor co-regulator system and patient outcome.
      datePublished:2007-09-28T00:00:00Z
      dateModified:2007-09-28T00:00:00Z
      pageStart:427
      pageEnd:437
      sameAs:https://doi.org/10.1007/s10549-007-9737-y
      keywords:
         Steroid receptor
         Co-regulator
         Breast cancer
         Co-repressor
         NCOR2/SMRT
         NCOA1/SRC-1
         NCOA3/RAC3
         CBP/p300
         Prognostic indicators
         Tissue micro-arrays
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-007-9737-y/MediaObjects/10549_2007_9737_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-007-9737-y/MediaObjects/10549_2007_9737_Fig2_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:110
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andrew R. Green
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claire Burney
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christopher J. Granger
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Claire Paish
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Somaia El-Sheikh
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emad A. Rakha
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Desmond G. Powe
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Douglas Macmillan
            affiliation:
                  name:Nottingham University Hospitals NHS Trust
                  address:
                     name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ian O. Ellis
            affiliation:
                  name:Nottingham University Hospitals NHS and University of Nottingham
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eleni Stylianou
            affiliation:
                  name:University of Nottingham Medical School, Queen’s Medical Centre
                  address:
                     name:School of Biomedical Sciences and Centre for Biochemistry and Cell Biology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:110
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS Trust
      address:
         name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS and University of Nottingham
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham Medical School, Queen’s Medical Centre
      address:
         name:School of Biomedical Sciences and Centre for Biochemistry and Cell Biology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andrew R. Green
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Claire Burney
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Christopher J. Granger
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:E. Claire Paish
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Somaia El-Sheikh
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Emad A. Rakha
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Desmond G. Powe
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:R. Douglas Macmillan
      affiliation:
            name:Nottingham University Hospitals NHS Trust
            address:
               name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Ian O. Ellis
      affiliation:
            name:Nottingham University Hospitals NHS and University of Nottingham
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Eleni Stylianou
      affiliation:
            name:University of Nottingham Medical School, Queen’s Medical Centre
            address:
               name:School of Biomedical Sciences and Centre for Biochemistry and Cell Biology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, Nottingham University Hospitals NHS and University of Nottingham, Nottingham, UK
      name:School of Biomedical Sciences and Centre for Biochemistry and Cell Biology, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(137)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.18s.